Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial
Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision tag 'Revision: v3.7.0' was added to the page, indicating the latest version of the study record. This update reflects the page’s revision history.SummaryDifference17%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a 2015 NIH grant/contract note and updated the page revision to v3.6.6, replacing v3.6.5.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now shows the full study record for the PF-ILD trial, replacing the previous error page and adding the study overview, design, outcomes, and list of participating sites.SummaryDifference100%

- Check55 days agoChange DetectedThe revision label on the page was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation/versioning. No study data or essential content appears to be changed.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's revision was bumped from v3.6.3 to v3.6.4, representing a small update to the page's metadata without changing the study details.SummaryDifference0.0%

- Check84 days agoChange DetectedPublication record updated: the Walters et al. cost-effectiveness paper moved from May 2026 online-ahead-of-print to the final July 2026 print publication in the Publications section of the study page.SummaryDifference0.0%

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.